From Impact
to Intervention
in Seconds.
Introducing BBT-101: a first-of-its-kind, intranasal therapy for concussions, designed to be fast, field-deployable, and effective.
A Breakthrough in Brain Injury Treatment.
Each year, an estimated 3 million people in the U.S. and 69 million globally suffer a concussion, from soldiers and athletes to everyday civilians. Yet 1 in 2 concussions go undiagnosed, and there’s still no FDA-approved treatment at the point of injury*.
Beyond Barriers Therapeutics is changing all that with the first frontline therapy for mild and moderate brain injury concussions, BBT-101. Built for the critical moments right after impact, BBT-101 is delivered intranasally to quickly reach the brain injury where it happens, when it matters most.
​
Learn more about BBT-101: the revolutionary drug, 50 years in the making that can change lives in seconds.
Backed by Data. Built for the Field.
Read about the Science & Solutions behind BBT-101,
backed by decades of clinical data and powered by a
proven compound.
Progress in Action.
Discover how BBT-101 is advancing through key milestones.